Neutrophil gelatinase-associated lipocalin and cystatin C for The prediction of clinical events in patients with advanced heart failure and after ventricular assist device placement

Journal of Heart and Lung Transplantation

Volumn 33, Issue 12, 2014, Pages 1215-1222

  Pronschinske, Katherine B ^a   Qiu, Sylvia ^a   Wu, Christina ^a   Kato, Tomoko S ^b   Khawaja, Tuba ^a   Takayama, Hiroo ^a   Naka, Yoshifumi ^a   Templeton, Danielle L ^a   George, Isaac ^a   Farr, Maryjane A ^a   Mancini, Donna M ^a   Christian Schulze, P ^a  

^a NewYork Presbyterian Hospital   (United States)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

cystatin C; heart failure; NGAL; renal function; ventricular assist device

Indexed keywords

CREATININE; CYSTATIN C; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DEVICE REMOVAL; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART RIGHT VENTRICLE FAILURE; HEART TRANSPLANTATION; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LEFT VENTRICULAR ASSIST DEVICE; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; PREDICTION; PRIORITY JOURNAL; PROGNOSTIC ASSESSMENT; RETROSPECTIVE STUDY; AGED; BLOOD; CASE CONTROL STUDY; COMPLICATION; HEART ASSIST DEVICE; HEART RIGHT VENTRICLE FUNCTION; HEMODYNAMICS; KIDNEY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ACUTE-PHASE PROTEINS; ADULT; AGED; BIOMARKERS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; CYSTATIN C; FEMALE; GLOMERULAR FILTRATION RATE; HEART FAILURE; HEART-ASSIST DEVICES; HEMODYNAMICS; HUMANS; KIDNEY; LIPOCALINS; MALE; MIDDLE AGED; PROGNOSIS; PROTO-ONCOGENE PROTEINS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 84923026042     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2014.06.007     Document Type: Article

References (21)

1. Heart Failure Society of America J. Lindenfeld, N.M. Albert, and J.P. Boehmer Heart Failure Society of America, HFSA 2010 comprehensive heart failure practice guideline J Card Fail 16 2010 e1 194
2. L.H. Lund, J. Matthews, and K. Aaronson Patient selection for left ventricular assist devices Eur J Heart Fail 12 2010 434 443
3. N. Pokhrel, N. Maharjan, and B. Dhakal Cardiorenal syndrome: a literature review Exp Clin Cardiol 13 2008 165 170
4. C. Ronco, and A. Maisel Volume overload and cardiorenal syndromes Congest Heart Fail 16 Suppl 1 2010 Si-iv; quiz Svi
5. E. Braunwald Biomarkers in heart failure N Engl J Med 358 2008 2148 2159
6. M.J. Sarnak, R. Katz, and C.O. Stehman-Breen Cystatin C concentration as a risk factor for heart failure in older adults Ann Intern Med 142 2005 497 505
7. K. Murata, N.A. Baumann, and A.K. Saenger Relative performance of The MDRD and CKD-EPI equations for estimating glomerular filtration rate among patients with varied clinical presentations Clin J Am Soc Nephrol 6 2011 1963 1972
8. J. Mishra, Q. Ma, and A. Prada Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury J Am Soc Nephrol 14 2003 2534 2543
9. J. Mishra, C. Dent, and R. Tarabishi Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery Lancet 365 2005 1231 1238
10. G. Wagener, M. Jan, and M. Kim Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery Anesthesiology 105 2006 485 491
11. M.M. Mitsnefes, T.S. Kathman, and J. Mishra Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in children with chronic kidney disease Pediatr Nephrol 22 2007 101 108
12. T.L. Nickolas, M.J. O'Rourke, and J. Yang Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury Ann Intern Med 148 2008 810 819
13. J. Malyszko, H. Bachorzewska-Gajewska, and E. Sitniewska Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in non-diabetic patients with stage 2-4 chronic kidney disease Renal Fail 30 2008 625 628
14. C.L. Dent, Q. Ma, and S. Dastrala Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study Crit Care 11 2007 R127
15. K.M. Schmidt-Ott, K. Mori, and A. Kalandadze Neutrophil gelatinase-associated lipocalin-mediated iron traffic in kidney epithelia Curr Opin Nephrol Hypertens 15 2006 442 449
16. M. Yanavitski, and M.M. Givertz Novel biomarkers in acute heart failure Curr Heart Fail Rep 8 2011 206 211
17. J. Lassus, and V.P. Harjola Cystatin C: a step forward in assessing kidney function and cardiovascular risk Heart Fail Rev 17 2012 251 261
18. L.W. Stevenson, F.D. Pagani, and J.B. Young INTERMACS profiles of advanced heart failure: The current picture J Heart Lung Transplant 28 2009 535 541
19. A. Yndestad, L. Landro, and T. Ueland Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure Eur Heart J 30 2009 1229 1236
20. A.A. Evangelopoulos, N.G. Vallianou, and V. Bountziouka Association between serum cystatin C, monocytes and other inflammatory markers Intern Med J 42 2012 517 522
21. W. Koenig, D. Twardella, and H. Brenner Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate Clin Chem 51 2005 321 327